Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 5
1983 2
1985 1
1987 1
1988 1
1989 5
1990 1
1991 4
1992 8
1993 5
1994 8
1995 6
1996 7
1997 5
1998 8
1999 9
2000 8
2001 5
2002 11
2003 9
2004 5
2005 7
2006 15
2007 13
2008 11
2009 4
2010 5
2011 6
2012 4
2013 10
2014 2
2015 13
2016 12
2017 13
2018 16
2019 15
2020 15
2021 15
2022 17
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

289 results

Results by year

Filters applied: . Clear all
Page 1
Primary biliary cholangitis: treatment.
Cazzagon N, Floreani A. Cazzagon N, et al. Among authors: floreani a. Curr Opin Gastroenterol. 2021 Mar 1;37(2):99-104. doi: 10.1097/MOG.0000000000000708. Curr Opin Gastroenterol. 2021. PMID: 33492001 Review.
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.
Nevens F, Andreone P, Mazzella G, Strasser SI, Bowlus C, Invernizzi P, Drenth JP, Pockros PJ, Regula J, Beuers U, Trauner M, Jones DE, Floreani A, Hohenester S, Luketic V, Shiffman M, van Erpecum KJ, Vargas V, Vincent C, Hirschfield GM, Shah H, Hansen B, Lindor KD, Marschall HU, Kowdley KV, Hooshmand-Rad R, Marmon T, Sheeron S, Pencek R, MacConell L, Pruzanski M, Shapiro D; POISE Study Group. Nevens F, et al. Among authors: floreani a. N Engl J Med. 2016 Aug 18;375(7):631-43. doi: 10.1056/NEJMoa1509840. N Engl J Med. 2016. PMID: 27532829 Free article. Clinical Trial.
Etiopathogenesis of autoimmune hepatitis.
Floreani A, Restrepo-Jiménez P, Secchi MF, De Martin S, Leung PSC, Krawitt E, Bowlus CL, Gershwin ME, Anaya JM. Floreani A, et al. J Autoimmun. 2018 Dec;95:133-143. doi: 10.1016/j.jaut.2018.10.020. Epub 2018 Oct 29. J Autoimmun. 2018. PMID: 30385083 Review.
Sex disparity and drug-induced liver injury.
Floreani A, Bizzaro D, Shalaby S, Taliani G, Burra P; Special Interest Group Gender in Hepatology of the Italian Association for the Study of the Liver (AISF). Floreani A, et al. Dig Liver Dis. 2023 Jan;55(1):21-28. doi: 10.1016/j.dld.2022.06.025. Epub 2022 Jul 15. Dig Liver Dis. 2023. PMID: 35843842 Review.
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.
Murillo Perez CF, Fisher H, Hiu S, Kareithi D, Adekunle F, Mayne T, Malecha E, Ness E, van der Meer AJ, Lammers WJ, Trivedi PJ, Battezzati PM, Nevens F, Kowdley KV, Bruns T, Cazzagon N, Floreani A, Mason AL, Parés A, Londoño MC, Invernizzi P, Carbone M, Lleo A, Mayo MJ, Dalekos GN, Gatselis NK, Thorburn D, Verhelst X, Gulamhusein A, Janssen HLA, Smith R, Flack S, Mulcahy V, Trauner M, Bowlus CL, Lindor KD, Corpechot C, Jones D, Mells G, Hirschfield GM, Wason J, Hansen BE; GLOBAL PBC Study Group and the members of the UK-PBC Consortium. Murillo Perez CF, et al. Among authors: floreani a. Gastroenterology. 2022 Dec;163(6):1630-1642.e3. doi: 10.1053/j.gastro.2022.08.054. Epub 2022 Sep 20. Gastroenterology. 2022. PMID: 36150526 Free article. Clinical Trial.
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?
Corpechot C, Lemoinne S, Soret PA, Hansen B, Hirschfield G, Gulamhusein A, Montano-Loza AJ, Lytvyak E, Pares A, Olivas I, Eaton JE, Osman KT, Schramm C, Sebode M, Lohse AW, Dalekos G, Gatselis N, Nevens F, Cazzagon N, Zago A, Russo FP, Floreani A, Abbas N, Trivedi P, Thorburn D, Saffioti F, Barkai L, Roccarina D, Calvaruso V, Fichera A, Delamarre A, Sobenko N, Villamil AM, Medina-Morales E, Bonder A, Patwardhan V, Rigamonti C, Carbone M, Invernizzi P, Cristoferi L, van der Meer A, de Veer R, Zigmond E, Yehezkel E, Kremer AE, Deibel A, Bruns T, Große K, Wetten A, Dyson JK, Jones D, Dumortier J, Pageaux GP, de Lédinghen V, Chazouillères O, Carrat F; Global & ERN Rare-Liver PBC Study Groups. Corpechot C, et al. Among authors: floreani a. Hepatology. 2024 Jan 1;79(1):39-48. doi: 10.1097/HEP.0000000000000529. Epub 2023 Jul 3. Hepatology. 2024. PMID: 37399238
Primary biliary cholangitis: Old and novel therapy.
Floreani A, Mangini C. Floreani A, et al. Eur J Intern Med. 2018 Jan;47:1-5. doi: 10.1016/j.ejim.2017.06.020. Epub 2017 Jun 29. Eur J Intern Med. 2018. PMID: 28669591 Review.
PBC and related extrahepatic diseases.
Floreani A, Cazzagon N. Floreani A, et al. Best Pract Res Clin Gastroenterol. 2018 Jun-Aug;34-35:49-54. doi: 10.1016/j.bpg.2018.05.013. Epub 2018 May 23. Best Pract Res Clin Gastroenterol. 2018. PMID: 30343710 Review.
COVID-19 and Autoimmune Liver Diseases.
Floreani A, De Martin S. Floreani A, et al. J Clin Med. 2022 May 10;11(10):2681. doi: 10.3390/jcm11102681. J Clin Med. 2022. PMID: 35628807 Free PMC article. Review.
Obeticholic Acid for Primary Biliary Cholangitis.
Floreani A, Gabbia D, De Martin S. Floreani A, et al. Biomedicines. 2022 Oct 2;10(10):2464. doi: 10.3390/biomedicines10102464. Biomedicines. 2022. PMID: 36289726 Free PMC article. Review.
289 results